e-learning
resources
Stockholm 2007
Monday 17.09.2007
New perspectives and old problems in diagnosing tuberculosis infection and disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Isoniazid protection and risk of tuberculosis in patients who used anti tumor necrosis factor-alpha treatment
O. Elbek, S. Borekci, M. Uyar, N. Bayram, H. Bayram, O. Dikensoy (Gaziantep, Turkey)
Source:
Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Session:
New perspectives and old problems in diagnosing tuberculosis infection and disease
Session type:
Oral Presentation
Number:
1775
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Elbek, S. Borekci, M. Uyar, N. Bayram, H. Bayram, O. Dikensoy (Gaziantep, Turkey). Isoniazid protection and risk of tuberculosis in patients who used anti tumor necrosis factor-alpha treatment. Eur Respir J 2007; 30: Suppl. 51, 1775
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases
Source: Eur Respir J 2009; 33: 586-593
Year: 2009
Re-activation of bovine tuberculosis in a patient treated with infliximab
Source: Eur Respir J 2008; 32: 229-231
Year: 2008
A screening for latent tuberculosis infection among candidates to anti-tumor necrosis factor-alpha agents using a whole blood interferon-gamma test
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
Source: Eur Respir J 2010; 36: 1185-1206
Year: 2010
Use of tuberculin skin test, IFN-gamma release assays and IFN-gamma-induced protein-10 to identify children with TB infection
Source: Eur Respir J 2013; 41: 644-648
Year: 2013
Relationship between the whole blood interferon-gamma responses and the risk of active tuberculosis
Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection
Year: 2006
Should isoniazid prophylaxis be prescribed to the patients under tumor necrosis factor-alpha antagonists independent of tuberculin skin test?
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Effect of prophylaxis on responses for ESAT-6/CFP-10 in whole blood IFN-g test
Source: Annual Congress 2005 - Genetics and immunobiology of tuberculosis
Year: 2005
Comparison of tuberculin skin test with an interferon-gamma based test in detecting candidates to latent tuberculosis infection treatment
Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI
Year: 2005
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement
Source: Eur Respir J 2009; 33: 956-973
Year: 2009
Comparison of a T-cell-based assay with tuberculin skin testing (TST) for diagnosis of latent tuberculosis infection (LTBI) in contact-tracing procedures
Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI
Year: 2005
New immunologic tools for the diagnosis and therapy of tuberculosis
Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem
Year: 2005
Implication of leptin, tumor necrosis factor-alpha, interleukin-1 and interleukin-6 in the pathogenesis of wasting in tuberculosis
Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection
Year: 2006
Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis
Source: Eur Respir J 2003; 21: 483-488
Year: 2003
Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis
Source: Eur Respir J 2007; 30: 321-332
Year: 2007
Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013
Using an interferon-γ assay for the diagnosis of tuberculosis infection before using tumor necrosis factor-α blockers
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
The incidence of tuberculosis in patients taking anti TNF alpha therapy
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011
Comparison between the antigen-specific interferon-gamma assay and the tuberculin skin testing for the detection of tuberculosis infection among BCG vaccinated schoolers at risk for tuberculosis exposure
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
Concordance between tuberculin skin testing and interferon-gamma release assays in diagnosis of latent tuberculosis infection among HIV-infected individuals
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept